vTv Therapeutics beats by $0.05, misses on revenue

• vTv Therapeutics (NASDAQ:VTVT): Q3 EPS of -$0.41 beats by $0.05.
• Revenue of $0.04M (-69.2% Y/Y) misses by $0.02M.
• Press Release